Literature DB >> 23052403

[Recommendations for symptomatic therapy of rheumatic pain with opioid analgetics].

W W Bolten1, S Reiter.   

Abstract

The treatment of musculoskeletal pain is often difficult. For this reason opioids are increasingly being used for chronic musculoskeletal complaints despite poor or lacking evidence for their pain relieving and function improving effects. However, side effects are common and can be severe. Opioid-induced hyperalgesia can lead to higher doses and stronger pain and increase the risk of side effects. Long-term treatment of rheumatic pain with opioids should be carried out with caution.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23052403     DOI： 10.1007/s00393-012-1026-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  36 in total

Review 1.  Consensus recommendations for the assessment and treatment of rheumatoid arthritis.

Authors:  F Wolfe; J J Cush; J R O'Dell; A Kavanaugh; J M Kremer; N E Lane; L W Moreland; H E Paulus; T Pincus; A S Russell; K R Wilskie
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

Review 2.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  K M Jordan; N K Arden; M Doherty; B Bannwarth; J W J Bijlsma; P Dieppe; K Gunther; H Hauselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; B Leeb; M Lequesne; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; U Serni; B Swoboda; G Verbruggen; I Zimmerman-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 3.  Opioid therapy for chronic pain.

Authors:  Jane C Ballantyne; Jianren Mao
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

4.  Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial.

Authors:  Richard Langford; Frank McKenna; Stuart Ratcliffe; Jozef Vojtassák; Ute Richarz
Journal:  Arthritis Rheum       Date:  2006-06

5.  Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.

Authors:  Larry F Chu; David J Clark; Martin S Angst
Journal:  J Pain       Date:  2006-01       Impact factor: 5.820

6.  Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial.

Authors:  Joseph A Markenson; Joseph Croft; P G Zhang; Patricia Richards
Journal:  Clin J Pain       Date:  2005 Nov-Dec       Impact factor: 3.442

7.  Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.

Authors:  Jacques R Caldwell; Ronald J Rapoport; Jeffrey C Davis; Howard L Offenberg; Howard W Marker; Sanford H Roth; William Yuan; Lise Eliot; Najib Babul; Pia Mikkelsen Lynch
Journal:  J Pain Symptom Manage       Date:  2002-04       Impact factor: 3.612

Review 8.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Authors:  W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2008-02       Impact factor: 6.576

Review 9.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

Review 10.  Tramadol for osteoarthritis: a systematic review and metaanalysis.

Authors:  M Soledad Cepeda; Francisco Camargo; Carlota Zea; Lina Valencia
Journal:  J Rheumatol       Date:  2007-03       Impact factor: 4.666
View more
  2 in total

1.  [Pain management in elderly patients].

Authors:  F Luttosch; C Baerwald
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

Review 2.  [DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain].

Authors:  W W Bolten; K Krüger; S Reiter-Niesert; D O Stichtenoth
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.